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HIV-1 transgenic mice on the FVB/NJ background (TgFVB) are
a well validated model of HIV-associated nephropathy
(HIVAN). A mapping study between TgFVB and CAST/EiJ
(CAST) strains showed this trait to be influenced by a major
susceptibility locus on chromosome 3A1–A3 (HIVAN1), with
CAST alleles associated with increased risk of disease. We
introgressed a 50 Mb interval, encompassing this HIVAN1
locus, from CAST into the TgFVB genome (TgFVB-HIVAN1CAST
congenic mice). Compared to the TgFVB strain, these
congenic mice developed an earlier onset of proteinuria, a
rapid progression to kidney failure, and increased mortality.
A prospective study of these congenic mice also showed that
they had a significantly greater histologic and biochemical
evidence of glomerulopathy with one-third of mice
developing global glomerulosclerosis by 6 weeks of age. An
F2 cross between TgFVB and the congenic mice identified a
significant linkage (LOD¼ 3.7) to a 10 cM interval within the
HIVAN1 region between D3Mit167 and D3Mit67 resulting in a
60% reduction of the original interval. These data
independently confirm that a gene on chromosome 3A1-A3
increases susceptibility to HIVAN, resulting in early onset and
rapid progression of kidney disease. These mice represent a
new model to study the development and progression of
collapsing glomerulopathy.
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HIV-1 infection is associated with a number of pathologically
distinct glomerulopathies that can lead to renal failure.1–6
Among these glomerulopathies, HIV-associated nephropathy
(HIVAN) is the most common form and is characterized by
the development of collapsing glomerulopathy and micro-
cystic tubular dilatation.5,6 Most patients with HIVAN
progress to end-stage renal failure without antiretroviral
therapy, directly implicating HIV-1 in the pathogenesis of
disease.4,7,8 Data suggest that HIVAN is produced by HIV-1-
induced dysregulation of glomerular podocytes, the highly
differentiated visceral epithelial cells lining the glomerular
filtration barrier.4 In HIVAN, podocytes exhibit enhanced
proliferation and apoptosis and lose signature proteins of
maturity such as podocin and synaptopodin.7,9,10 The
mechanism underlying the dysregulated podocyte phenotype
is not fully understood. HIV-1 has been shown to interfere
with multiple pathways that are critical for maintaining
cellular quiescence, with the HIV-1 nef protein as an
important pathogenic mediator.10–18
Host genetic factors also have an important impact on the
course of HIV-1 infection and the development of complica-
tions.3,19,20 For example, the progression of HIV-1 disease is
influenced by HLA genotype21 or copy number variation at
the CCL3L1 locus,20 and the development of dementia is
influenced by APOE alleles.22 Several lines of evidence also
suggest that host genetic factors are also important for the
development of HIVAN. Contrary to other glomerular
diseases associated with HIV-1 infection, HIVAN almost
exclusively occurs in individuals of African ancestry.1,2,23,24
Moreover, family members of HIVAN patients also have a
higher incidence of end-stage renal disease, suggesting
segregation of nephropathy-predisposing alleles in these
families.25 Most recently, studies have shown that sequence
variants in the podocyte-expressed non-muscle myosin heavy
chain gene (MYH9) are associated with multiple nephro-
pathies including HIVAN, explaining these epidemiological
observations among African Americans.26,27
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Multiple murine models of HIVAN have been developed
and highlight the importance of permissive genetic back-
ground on the development of this trait. Introduction of the
HIV-1 proviral genome, or specific HIV-1 genes (such as nef)
into the mouse genome reproduces all the clinical and
pathological features of HIVAN.15–18,28 However, the devel-
opment of disease is highly strain dependent. Studies using
independent transgene constructs have shown that the FVB/
NJ (FVB) genetic background is highly permissive, resulting
in all the manifestations of collapsing glomerulopa-
thy.17,18,28,29 To examine the impact of host genetic factors,
we previously produced F1 hybrids between HIV-1 transgenic
FVB lines (TgFVB) and six inbred strains and found wide
variation in penetrance of disease.29 Using a cross between
TgFVB and the CAST/EiJ (CAST) strain, we identified a
major susceptibility locus for HIVAN on chromosome
3A1–A3, which we named HIVAN1.29 Interestingly, at the
HIVAN1 locus, CAST alleles were associated with increased
severity of disease. However, the HIVAN1 95th percentile
confidence interval spanned over 50 Mb, necessitating addi-
tional experiment for identification of the underlying gene.
Derivation of congenic lines trapping susceptibility loci is
a powerful approach for replication of linkage findings and
subsequent elucidation of complex traits.30 Congenic lines
are produced by introgressing chromosomal segments
encompassing the quantitative trait loci (QTL) of interest
from a donor strain into a recipient strain, thereby enabling
analysis of alternative alleles of the QTL within the same
genetic background.31 This procedure provides independent
verification of the initial linkage studies, enables better
characterization of the phenotypic effect imparted by the
QTL, and facilitates gene identification by fine mapping or
derivation of subcongenic lines.30,31 Toward identification of
the HIVAN1 gene, we produced mice congenic for the
HIVAN1 interval and report genetic and phenotypic analysis
of this new model of nephropathy.
RESULTS
We produced HIVAN1 mice congenic (named the TgFVB-
HIVAN1CAST strain) by introducing the chromosome seg-
ment encompassing this interval from CAST into the FVB
genome by 10 generations of backcrossing. A genome scan
with 82 informative loci in the 10th backcross generation
confirmed that the TgFVB-HIVAN1CAST strain possessed a
pure FVB genetic background outside the introgressed
region. The proximal and distal loci homozygous for CAST
alleles were delimited by rs6372626 (located at 4.2 Mb on the
mouse reference sequence) and rs13477119 (54.6 Mb),
respectively; the next proximal and distal markers homo-
zygous for FVB alleles were rs6171250 (3 Mb) and
rs30305237 (55.8 Mb), respectively. Thus the size of the
congenic segment spans from a minimum of 50.4 Mb to a
maximum of 52.8 Mb.
Nontransgenic FVB-HIVAN1CAST mice were phenotypi-
cally normal with no evidence of nephropathy or proteinuria.
However, HIV-1 transgenic counterparts developed rapid
onset of kidney disease (Figure 1) withB40% mortality rate
at 8 weeks of age (compared too5% for TgFVB). Moreover,
by 4 weeks of age, HIV-1 transgenic TgFVB-HIVAN1CAST
mice displayed increased incidence of proliferative epidermal
lesions characteristic of animals expressing this HIV-1-
transgene construct,32 necessitating euthanasia based on
humane criteria. Therefore, to prospectively study the impact
of HIVAN1 alleles on the development of kidney disease, a
cohort of TgFVB-HIVAN1CAST mice were studied from birth
to 6 weeks of age and compared to TgFVB counterpart. At 3
weeks of age, all HIV-1 transgenic mice displayed significant
proteinuria compared to nontransgenic mice, but homo-
zygosity for CAST alleles was associated with a twofold
increase in albuminuria (Po0.04; Figure 2a). At 6 weeks of
age, TgFVB-HIVAN1CAST mice continued to display signifi-
cantly greater proteinuria compared to TgFVB mice
(Po0.02; Figure 2a). On histologic assessment, TgFVB-
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Figure 1 | Histology of TgFVB-HIVAN1CAST mice (PAS stain). Congenic mice display advanced global glomerulosclerosis (a–c) or
collapsing glomerulosclerosis with podocyte hyperplasia (d–f). (a and d) Low power view ( 200) demonstrates diffuse and global
glomerulosclerosis, extensive microcystic tubular dilatation and severe tubulointerstitial injury. (b and c) High power views ( 400) of
glomeruli showing global sclerosis and podocyte depletion. Higher power views ( 600) of glomeruli showing collapsing sclerosis (e) with
podocyte hyperplasia and cytoplasmic vacuolization (f).
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HIVAN1CAST demonstrated hallmarks of collapsing glomer-
ulopathy, including tuft collapse and overlying podocyte
proliferation and hypertrophy (Figure 1). Quantitative
comparison of renal histopathology demonstrated signifi-
cantly increased glomerulosclerosis (P¼ 0.003; Figure 2b)
and tubular injury with microcystic dilatation (P¼ 0.002;
Figure 2b) in TgFVB-HIVAN1CAST compared to TgFVB mice.
Interestingly, 9/25 TgFVB-HIVAN1CAST animals also demon-
strated global glomerulosclerosis with extensive podocyte
depletion at 6 weeks of age, a finding that was not observed in
their TgFVB counterparts (P¼ 0.002 on Fisher’s exact test).
Heterozygous mice also displayed increased pathology,
intermediate between FVB/FVB and CAST/CAST, consistent
with an additive effect of CAST alleles (Figure 2a and b).
Previous studies in TgFVB mice have shown that the
development of nephropathy coincides with increased expres-
sion of the HIV-1 transgene, followed by gradual reduction in
expression secondary to loss of renal epithelial cells accom-
panying progressive renal injury.27 To assess whether increased
severity of kidney disease in TgFVB-HIVAN1CAST mice is
attributable to enhanced transgene expression, we quantitated
transgene expression in 10 CAST/CAST and 10 FVB/FVB
congenic mice with mild to moderate renal injury. These mice
were matched for severity of renal histology scores to avoid bias
introduced by secondary decrease in transgene expression due
to nephropathy. There were no differences in transgene
expression between the two genotype groups (Figure 2c),
suggesting that increased severity of kidney disease is mediated
through variation in host response to HIV-1 rather than
enhanced expression of the transgene.
These data demonstrate successful trapping of the
HIVAN1 susceptibility alleles in our congenic strain, provid-
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Figure 2 | Phenotypic comparison of TgFVB and TgFVB-HIVAN1CAST mice. Comparison of proteinuria (a) and glomerulosclerosis scores
(b) in HIV-1 transgenic mice carrying different alleles at the HIVAN1 locus on chromosome 3A1–A3. Values for a cohort of nontransgenic
(nonTg) mice of all three genotypes are shown for comparisons. (c) Comparison of HIV-1 Env expression in mice carrying different alleles at
the HIVAN1 locus. #Po0.005, *Po0.05 vs Tg FVB/FVB genotype.
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Figure 3 | Fine mapping of the HIVAN1 locus. (a) LOD plots for renal histology scores in the F2 intercross between TgFVB and TgFVB-
HIVAN1CAST strains. Map distance is presented in cM. The positions of informative markers are shown above each plot. The dashed
horizontal lines indicate the empiric threshold for 95th and 99th percentile significance level based on 10,000 permutations (1.9 and 3.2,
respectively). The 95th confidence interval for the location of the HIVAN1 gene is shown above the LOD plot. (b) Phenotypic effects of
HIVAN1 genotype in F2 cross is consistent with an additive model (mean±s.e.m.).
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ing a novel tool for identifying the underlying susceptibility
allele. We next utilized this strain to achieve further
refinement of the HIVAN1 interval by meiotic mapping.
We produced an F2 intercross between TgFVB and FVB-
HIVAN1CAST strains and phenotyped 68 F2 progeny.
Genotypic analysis with seven informative markers demon-
strated significant linkage of renal histology score with the
HIVAN1 locus (peak LOD 3.7, empiric P¼ 0.001 and 3.3,
empiric P¼ 0.004, at D3Mit224 for glomerular and tubular
injury scores, respectively; Figure 3a). As a single interval was
tested, these LOD scores achieve pointwise significance for
replication (Po0.01) and remarkably, also exceed published
genome-wide significance.33 In this cross, the HIVAN1 alleles
demonstrated an additive effect (Figure 3b), explaining 20
and 12% of the variance in the glomerulosclerosis and
tubular injury scores. The effect sizes were also consistent
with observations in the congenic lines (Figure 3b). As this
cross was produced on a homogeneous background, the
linkage peak was much narrower than the original study, with
the 95% confidence limit localizing the HIVAN1 gene within
a B10 cM interval delimited by D3Mit167 and D3Mit67
(corresponding to B32–52 Mb position in mouse reference
sequence), a region containing 126 genes. This represents a
60% reduction in the original HIVAN1 interval.
As laboratory mouse strains are derived from a limited set
of ancestors, comparison of haplotype structure across inbred
strains can identify segments that are identical by descent
(IBD), enabling further higher resolution mapping of linkage
regions.34,35 We therefore examined the haplotype structure
of the refined region and identified genes that contain
informative single nucleotide polymorphisms (SNPs) be-
tween FVB and CAST. We identified 46,004 SNPs within the
critical regions that are polymorphic between CAST and FVB
(1 SNP/394 bp). Among these, 3684 SNPs are located within
78 NCBI annotated genes, but the remaining genes could not
be studied due to lack of SNP data in either FVB or CAST
strains. Among these 78 genes with non-IBD haplotypes, 22
genes harbor nonsynonymous variants, providing an initial
selection tool for prioritization of genes within this interval
(total of 95 SNPs; Supplementary Data). The high poly-
morphism rate between the CAST and FVB strains is
consistent with the wild-derived origin of CAST strain and
its relatively low contribution to the laboratory mouse
genome, suggesting that comparison of IBD structure
between FVB and CAST would not significantly refine the
interval further.34
DISCUSSION
In this study, we characterized a novel congenic strain that
exhibits rapid onset and increased severity of HIVAN.
Introgression of CAST alleles at the HIVAN1 locus into the
FVB genome resulted in earlier onset of disease, as evidenced
by greater proteinuria at 3 weeks of age, worse histologic
features and proteinuria at 6 weeks of age and early demise.
In addition, many animals developed global glomerulo-
sclerosis and podocyte depletion, a feature rarely observed in
younger TgFVB mice. These congenic lines enabled better
resolution of the QTL by isolating it in a homogeneous
genetic background. Analysis of TgFVB-HIVAN1CAST con-
genic lines also enabled better characterization of the QTL
effect size, demonstrating that it accounts for 12–20% of the
variance in renal injury and is associated with a twofold
higher glomerulosclerosis score and proteinuria by 6 weeks of
age. These effects are very significant considering that our
original mapping study relied on phenotypic characterization
at 12 weeks of age, allowing more time for nephropathy to
develop.29 Analysis of heterozygotes supported an additive
genetic model, which was further confirmed by an F2
mapping cohort. These data independently confirm our
initial mapping study, demonstrating that a gene on
chromosome 3A1–A3 mediates susceptibility to HIVAN.
The TgFVB-HIVAN1CAST congenic strain now offers a novel
tool for identifying the gene(s) mediating increased suscept-
ibility to HIVAN and studying the pathogenesis of this
disease. As both TgFVB and TgFVB-HIVAN1CAST strains
develop nephropathy, it is unclear whether HIVAN1 alleles
directly contribute to the development of HIVAN or
primarily affect progression of disease. Therefore, it will be
interesting to determine whether HIVAN1 alleles exacerbate
other forms of nephropathy, or whether similar to older
haploinsufficient Cd2ap or Actn4 mice,36,37 the underlying
susceptibility state will manifest with mild proteinuria or
subtle ultrastructural defects in aged nontransgenic FVB-
HIVAN1CAST mice.
Additional refinement of the HIVAN1 interval can be
achieved by systematic derivation of subcongenic lines that
can further dissect the region into smaller segments and can
determine whether this genetic interval harbors a single- or
multiple-linked QTLs. Alternatively, meiotic mapping in
congenic lines can further resolve the interval to a tractable
segment for gene identification. Although analysis of
haplotype structure had previously been helpful for refine-
ment of a nephropathy locus among classic laboratory
strains,35 this strategy was not useful in this study because
the wild-derived CAST strain has a relatively minor
contribution to the laboratory mouse genome. Hence, most
segments of the HIVAN1 interval harbor polymorphisms
between FVB and CAST, complicating identification of the
functional allele(s). Meiotic mapping appears to be the most
feasible option, as demonstrated by significant linkage to
smaller, well defined region obtained with our modest sized
F2 cohort. This F2 cross indicated that a single QTL
segregates within the HIVAN1 locus, suggesting that genera-
tion of larger mapping cohorts would rapidly resolve the
interval further. An examination of positional candidates in
the current 95% confidence interval reveals that nearly half
are minimally annotated. Interestingly, ontology searches of
the annotated genes reveal significant enrichment for genes
encoding calcium dependent proteins (Anxa5, Trpc3, Pcdh18,
Pcdh10, Cetn4, Fat4) or JAK-STAT signaling (Spry1, Il21, Il2).
Other potentially relevant candidates include genes with
known interaction with HIV-1 such as Fgf2, Pik3ca, Il2, and
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Ccna2, which are involved in some of the principle pathways
affected by HIV-1 infection such as cell cycle regulation or
cytokine production. We anticipate that gene expression
analysis in FVB-HIVAN1CAST strains will provide additional
information for prioritization of genes by identifying
differentially expressed renal transcripts. Any genes that are
differentially expressed and located within the critical interval
would represent strong positional candidates that should be
pursued by functional studies or transgenesis experiments.
Collapsing glomerulopathy can be caused by many
different primary insults to glomerular podocytes. In HIVAN
and other forms of collapsing glomerulopathy, the prolifer-
ating podocytes are gradually depleted, undermining the
architecture of the glomerular filtration barrier. Ultrastruc-
turally, collapsing glomerulopathy is characterized by actin
cytoskeletal effacement, whereas other forms of focal
segmental glomerulosclerosis are associated with reorganiza-
tion of the actin cytoskeleton into mats.38 Known environ-
mental triggers for this lesion include infectious agents
(HIV-1, cytomegalovirus) or drugs (bisphosphonates, inter-
pheron-a).4,39 Inherited disorders featuring collapsing
glomerulopathy have also been reported.40 In humans,
noncoding variants in the MYH9 gene were recently
associated with HIVAN, primary focal segmental glomerulo-
sclerosis or nondiabetic end-stage renal failure.26,27 Muta-
tions in the coding sequence of MYH9 have dominant,
pleiotropic effects in extrarenal tissues but are sometimes
associated with nephropathy.41 Interestingly, Myh9 haploin-
sufficient mice are phenotypically normal, suggesting that
additional genetic or environmental modifier may be
required for manifestation of the complications observed in
humans.42,43 Myh9 is located on chromosome 15 in the
mouse and is therefore distinct from the HIVAN1 gene, but
given the close similarity of the TgFVB model to the human
disease, it is likely that HIVAN1 operates in the same pathway
as Myh9. Cross-breeding studies with HIV-1 transgenic mice
and the FVB-HIVANCAST strain can determine the relation-
ship among HIV-1, Myh9, and HIVAN1.
In addition to HIV-1 transgenic mice, several animal
models have also been developed, highlighting novel path-
ways underlying this lesion. For example, collapsing glomer-
ulopathy in kd/kd mice is due to a mutation in the gene
encoding prenyl diphosphate synthase, subunit 2 (Pdss2),
resulting defective mitochondrial CoQ biosynthesis.44 Tissue
specific expression of mutant alleles resulted in biochemical
defects of CoQ9 and CoQ10 deficiency, but expression in
podocytes was necessary and sufficient to recapitulate the full
renal phenotype.45 Similarly, Henderson et al. have reported
that mice homozygous for Actn4 null alleles, or a human
disease associated Actn4 mutation also develop collapsing
glomerulopathy, whereas mice heterozygous for the human
mutation only manifest mild ultrastructural changes.37 Actn4
and Pssd2 operate in widely disparate pathways, complicating
inference of a common mechanism for the development of
collapsing glomerulopathy. Moreover, as both Actn4 and
Pssd2 are ubiquitously expressed, the reasons for the unique
vulnerability of podocytes are not known. It is generally
hypothesized that podocytes are particularly susceptible to
injury because they are terminally differentiated and cannot
repopulate subsequent to genetic or environmental insults.4
The remaining podocytes must therefore undergo hypertro-
phy to cover a larger surface area, leaving denuded segments
of the basement membrane that promote the development of
sclerotic lesions. Finally, beyond as certain threshold,
podocyte injury may spread locally, further propagating the
segmental sclerotic process.46 However, the molecular path-
ways linking podocyte injury, cytoskeletal remodeling,
propagation of injury, and glomerulosclerosis remains
unclear. The availability of different models now enables
systematic cross-comparative studies, which may provide
additional insight into shared mechanisms underlying
collapsing glomerulopathy.
MATERIALS AND METHODS
Animal breeding
The HIV-1 transgenic mouse line TgN(pNL43d14)26Lom 26
(TgFVB) was produced on the inbred FVB/NJ genetic background
and has been extensively characterized. The TgFVB colony at
Columbia University has been continuously backcrossed to FVB/NJ
for at least 30 generations. Congenic mice for the HIVAN1 locus
were generated by generating F1 hybrid between FVB/NJ and CAST/
EiJ followed by 10 generations of backcrossing to FVB/NJ with
selection of CAST alleles across the HIVAN1 locus at each
generation. As HIV-1 transgenic mice develop kidney disease,
wild-type FVB/NJ mice were utilized for nine generations of
backcrossing, yielding mice that were heterozygotes for CAST alleles
the HIVAN1 locus at each generation. We then utilized TgFVB for
the 10th backcross generation, yielding HIV-1 transgenic mice with
FVB/CAST genotype at the HIVAN1 locus. Trangenic heterozygous
mice were intercrossed with nontransgenic heterozygous mice to
yield transgenic mice with CAST/CAST, CAST/FVB, or FVB/FVB
genotypes at the HIVAN1 locus. Mice carrying the full-length
haplotype across the interval were selected for study. The markers
utilized for derivation of the congenic intervals were D3Mit61
(5.1 Mb), D3Mit203 (26.8 Mb), and D3Mit67 (52.8 Mb). Subse-
quently the boundaries of the congenic region were better delineated
by SNP genotyping. Successful introgression of the HIVAN1 interval
into the FVB/NJ genetic background was further confirmed by
typing 82 informative loci across the genome in the 10th backcross
generation (Kbioscience, Hoddesdon, UK), which confirmed that
congenic mice carried only FVB alleles outside the HIVAN1 interval.
For characterization of congenic mice, the study endpoint was
limited to 6 weeks of age because of increased mortality and
development of skin lesions. Histology was compared between mice
of differing genotypes at the HIVAN1 locus (FVB/FVB, N¼ 30;
FVB/CAST, N¼ 26; CAST/CAST, N¼ 22). In a subset of congenic
mice, we quantitated albumin/creatinine ratio (Exocell, Philadel-
phia, PA, USA) at 3 and 6 weeks of age (FVB/FVB, N¼ 16; FVB/
CAST, N¼ 17; CAST/CAST, N¼ 19). Fifteen nontransgenic mice of
all three genotype class were also tested as controls.
We also produced an independent cohort of 68 F2 mice for
meiotic mapping. For this cross, we produced F1 hybrids between
FVB-HIVAN1CAST congenic mice and TgFVB and cross-bred a
transgenic to a nontransgenic F1 hybrid to generate F2 intercross
mice. Renal histology was scored independently by an investigator
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(VDD) blinded to genetic background and other traits, scoring the
severity of tubulointerstitial disease (tubular casts, tubular dilata-
tion, epithelial regeneration/degeneration) and glomerular injury
(segmental and global glomerulosclerosis and collapse, podocyte
hyperplasia and collapse) using a continuous and a semiquantitative
scale: 0¼ no disease, 1¼ 1–25% of glomeruli or tubular area
showing abnormalities, 2¼ 26–50%, 3¼ 51–75%, and 4475% of
tissue affected. The protocol was approved by the IACUC committee
at the Columbia University Medical Center.
Genotyping and analysis of linkage
The F2 cohort was genotyped using seven informative microsatellite
markers across the HIVAN1 locus (Figure 3). Multipoint analysis of
linkage was performed using the R/QTL package.47 As the renal
injury scores were not normally distributed, a nonparametric model
was used. In addition, we conducted 10,000 permutations of
phenotypes on genotype to determine the empirical significance of
the linkage findings.
Statistical and bioinformatics analysis
Statistical analyses were performed using SPSS. The primary
endpoints were the comparison of proteinuria and histologic injury
between TgFVB and FVB-HIVAN1CAST strains using two-sided
t-test. P-valuesp0.05 were considered significant. SNP ID and
annotation across the HIVAN1 interval were obtained from the
Mouse Phenome Database (http://aretha.jax.org/pub-cgi/phenome/
mpdcgi?rtn=docs/home). Non-IBD segments were identified by
filtering for polymorphic SNP between FVB/NJ and CAST/eiJ
strains. Gene annotation was performed using the PANTHER
database (http://www.pantherdb.org/).
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